Latest filing published 10 Dec 2020 for Seer, Inc., €1.6M.
Filing timeline
BuySaleInsider track record
Closed purchases
Based on 3 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- -66.2%Entry US$75.65 · Close at T+365 US$25.56
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
aMoon 2 Fund Limited Partnership: trading record in brief
Filings by aMoon 2 Fund Limited Partnership span 2 companies, the busiest being Seer, Inc. and Ayala Pharmaceuticals, Inc. Over a trading history stretching from 12 May 2020 to 9 December 2020, the count stands at 8 filings.
Every open-market trade on record is a purchase: 4 purchases worth €25.0M, and no sale. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant.
In size, the median ticket on the buying side is €6.3M. 4 out of 4 purchases came within 30 days of a purchase by at least one other insider of the same company. Purchases made close together by different insiders form what is called a cluster. After 3 purchases with a full 90-day history, the hit rate stands at 0% and the median 90-day move at -35.6%. Past outcomes like these are no guarantee of what comes next.
The latest filing, published on 10 December 2020, reports an open-market purchase of €1.6M in Seer, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. US insiders must file a Form 4 within two business days of a trade. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to aMoon 2 Fund Limited Partnership
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 100,000 shares@ US$19.0011.2% of flowClass A Common StockSEC:0001628280-20-017345:1Canonical exit: 8 Mar 2021 (T+90)
- 726,449 shares@ US$19.0081.7% of flowClass A Common StockSEC:0001628280-20-017345:2Canonical exit: 9 Mar 2021 (T+90)
- 4,121,064 sharesClass A Common StockSEC:0001628280-20-017345:0
- 912,659 sharesClass A Common StockSEC:0001628280-20-017345:3
- 63,024 shares@ US$19.007.1% of flowClass A Common StockSEC:0001628280-20-017345:4Canonical exit: 9 Mar 2021 (T+90)
- 369,231 shares0Common StockSEC:0000899243-20-013089:0
- 508,924 shares0Common StockSEC:0000899243-20-013089:1
- 800,000 shares@ US$15.00100.0% of flowCommon StockSEC:0000899243-20-013089:2Canonical exit: 10 Aug 2020 (T+90)
8 of 8 declarations
